Heidelberg Pharma GmbH
Records under this name other than the patents Heidelberg Pharma GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Heidelberg Pharma GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,399,681 | Amatoxin-conjugates with improved linkers Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,676,702 | Methods for synthesizing amatoxin building block and amatoxins Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,419,965 | Nucleotide lipid ester derivatives Lapsed on the fee record Ended Sep 2, 2012 · USPTO record | Lapsed on the fee record | Ended Sep 2, 2012 | USPTO record |
| US 7,378,401 | Use of Fosfluridine Tidoxil (FT) for the treatment of intraepithelial proliferative diseases Lapsed on the fee record Ended May 27, 2012 · USPTO record | Lapsed on the fee record | Ended May 27, 2012 | USPTO record |
| US 6,025,343 | Lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs Lapsed on the fee record Ended Feb 15, 2012 · USPTO record | Lapsed on the fee record | Ended Feb 15, 2012 | USPTO record |
| US 6,521,262 | Solid instant-release forms of administration and process for producing the same Lapsed on the fee record Ended Feb 18, 2011 · USPTO record | Lapsed on the fee record | Ended Feb 18, 2011 | USPTO record |
| US 7,176,011 | Lipid cleavage enzyme Lapsed on the fee record Ended Feb 13, 2011 · USPTO record | Lapsed on the fee record | Ended Feb 13, 2011 | USPTO record |
| US 6,177,469 | Lipid alcohols as new immunosuppressive and antiviral drugs Lapsed on the fee record Ended Jan 23, 2009 · USPTO record | Lapsed on the fee record | Ended Jan 23, 2009 | USPTO record |
| US 6,136,797 | Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments Lapsed on the fee record Ended Oct 24, 2008 · USPTO record | Lapsed on the fee record | Ended Oct 24, 2008 | USPTO record |
| US 6,080,734 | Liponucleotides of seco-nucleosides, their production as well as their use as antiviral pharmaceutical agents Lapsed on the fee record Ended Jun 27, 2008 · USPTO record | Lapsed on the fee record | Ended Jun 27, 2008 | USPTO record |